REVB
REVB
NASDAQ · Biotechnology

Revelation Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.03
-0.02 (-1.90%)
As of May 16, 2:36 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +891.3% upside
Low Target $7.91
Average Target $10.21
High Target $15.75
Current Price $1.03
Current
$1.03
Target
$10.21
$7.91 $10.21 avg $15.75
Scenario Analysis
Bear Case
$7.91
668.0%
Low target
Base Case
$10.21
+891.3%
Avg target
Bull Case
$15.75
+1,429.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$39.88
-97.4% from high
52-Week Low
$0.88
+17.7% from low
Target vs 52W High
$10.21
-74.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%